Neuroprotective effects of perflurocarbon (oxycyte) after contusive spinal cord injury

Journal of Neurotrauma

Volumn 31, Issue 3, 2014, Pages 256-267

  Yacoub, Adly ^a   Hajec, Marygrace C ^a   Stanger, Richard ^a   Wan, Wen ^b   Young, Harold ^a   Mathern, Bruce E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

apoptosis; ischemia; spinal cord injury

Indexed keywords

BUPRENORPHINE; ENROFLOXACIN; FLUOROCARBON; GENTAMICIN; OXYCYTE; PERFLUROCARBON; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CONTUSION; CONTUSIVE SPINAL CORD INJURY; DISEASE SEVERITY; EMULSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; RAT; SPINAL CORD; SPINAL CORD INJURY; TREATMENT OUTCOME; URINARY TRACT INFECTION; WHITE MATTER;

ANIMALS; DISEASE MODELS, ANIMAL; FLUOROCARBONS; IMMUNOHISTOCHEMISTRY; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; RATS; RATS, LONG-EVANS; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 84893135752     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.3037     Document Type: Article

References (55)

1. Bunge, R.P., Puckett, W.R., Becerra, J.L., Marcillo, A., and Quencer, R.M. (1993). Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv. Neurol. 59, 75-89.
2. Baptiste, D.C., and Fehlings, M.G. (2007). Update on the treatment of spinal cord injury. Prog. Brain Res. 161, 217-233.
3. Simon, M.C., Sharif, S., Tan, P.R., and LaPlaca, C.M. (2009). Spinal cord contusion causes acute plasma membrane damage. J. Neurotrauma 26, 563-574.
4. Tator, C.H. (2006). Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations. J. Neurosurg. 59, 957-987.
5. Kwon, B.K., Tetzlaff, W., Grauer, J.N., Beiner, J., and Vaccaro, A.R. (2004). Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 4, 451-464.
6. Norenberg, M.D., Smith, J., and Marcillo, A. (2004). The pathology of human spinal cord injury: defining the problems. J. Neurotrauma 21, 429-440.
7. Schwab, M.E., and Bartholdi, D. (1996). Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 76, 319-370.
8. Tator, C.H., and Fehlings, M.G. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26.
9. Tator, C.H., and Izumi, K. (1997). Vascular mechanisms in the pathophysiology of human spinal cord injury. J. Neurosurg. 86, 483-492.
10. Young, W. (1993). The therapeutic window for methylprednisolone treatment of acute spinal cord injury: implications for cell injury mechanisms. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 71, 191-206.
11. Anderson, D.K., Means, E.D., Waters, T.R., and Spears, C.J. (1980). Spinal cord energy metabolism following compression trauma to the feline spinal cord. J. Neurosurg. 53, 375-380.
12. Anthes, D., Elizabeth, T., and Tator, C. (1996). Ultrastructural evidence for arteriolar vasospasm after spinal cord trauma. Neurosurgery 39, 804-814.
13. Hulsebosch, C.E. (2002). Recent advances in pathophysiology and treatment of spinal cord injury. Adv. Physiol. Educ. 26, 238-255.
14. McCord, J.M. (1985). Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312, 159-163.
15. Popovich, P.G., Horner, P.J., Mullin, B.B., and Stokes, B.T. (1996). A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp. Neurol. 142, 258-275.
16. Rivlin, A.S., and Tator, C.H. (1978). Regional spinal cord blood flow in rats after severe cord trauma. J. Neurosurg. 49, 844-853.
17. Wallace, M.C., Tator, C.H., and Frazee, P. (1986). Relationship between posttraumatic ischemia and hemorrhage in the injured rat spinal cord as shown by colloidal carbon angiography. Neurosurgery 18, 433-439.
18. Sasaki, S., Schneider, H., and Renz, S. (1978). Microcirculatory disturbances during the early phase following experimental spinal cord trauma in the rat. Adv. Neurol. 20, 423-431.
19. Balentine, J.D. (1978). Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab. Invest. 39, 236-253.
20. Fehlings, M.G., and Baptiste, D.C. (2005). Current status of clinical trials for acute spinal cord injury. Injury 36, B113-B122.
21. Park, E., Velumian, A.A., and Fehlings, M.G. (2004). The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J. Neurotrauma 21, 754-774.
22. Fehlings, M.G., Tato, C.H., and Linden, R.D. (1989). The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroencephalogr. Clin. Neurophysiol. 74, 241-259.
23. Ishizaki, M., Sugiyama, S., Uchida, H., Nawa, S., and Shimizu, N. (1997). Intrathecal oxygen concentration as a new indicator of spinal cord ischemia. Acta Med. Okayama 51, 71-77.
24. Kelly, D.L., Jr., Lassiter, K.R., Vongsvivut, A., and Smith, JM. (1972). Effects of hyperbaric oxygenation and tissue oxygen studies in experimental paraplegia. J. Neurosurg. 36, 425-429.
25. Leese, P.T., Noveck, R.J., Shorr, J.S., Woods, C.M., Flaim, K.E., and Keipert, P.E. (2000). Randomized safety studies of intravenous perfluorocabron emulsion. I. Effects on coagulation function in healthy volunteers. Anesth. Analg. 91, 804-811.
26. Spiess, B.D. (2009). Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamics. J. Appl. Physiol. 106, 1444-1452.
27. Sakas, D.E., Whittaker, K.W., Crowell, R.M., and Zervas, N.T. (1996) Perfluorocarbons: recent developments and implications for neurosurgery. J. Neurosurg. 85, 248-254.
28. Cochran, R.P., Kunzelman, K.S., Vocelka, C.R., Akimoto, H., Thomas, R., Soltow, L.O., and Spiess, B.D. (1997). Perfluorocarbon emulsion in the cardiopulmonary bypass prime reduces neurologic injury. Ann. Thorac. Surg. 63, 1326-1332.
29. Daugherty, W.P., Levasseur, J.E., Sun, D., Spiess, B.D., and Bullock, M.R. (2004). Perfluorocarbon emulsion improves cerebral oxygenation and mitochondrial function after fluid percussion brain injury in rats. Neurosurgery 54, 1223-1230.
30. Gale, S.C., Gorman, G.D., Copeland, J.G., and McDonagh, P.F. (2007). Perflubron emulsion prevents PMN activation and improves myocardial functional recovery after cold ischemia and reperfusion. J. Surg. Res. 138, 135-140.
31. Kwon, T.H., Sun, D., Daugherty, W.P., Spiess, B.D., and Bullock, M.R. (2005). Effect of perfluorocarbons on brain oxygenation and ischemic damage in an acute subdural hematoma model in rats. J. Neurosurg. 103, 724-730.
32. Woitzik, J., Weinzierl, N., and Schilling, L. (2005). Early administration of a second-generation perfluorochemical decreases ischemic brain damage in a model of permanent middle cerebral artery occlusion in the rat. Neurol. Res. 27, 509-515.
33. Zhou, Z., Sun, D., Levasseur, J.E., Merenda, A., Hamm R.J., Zhu, J., Spiess, B.D., and Bullock, M.R. (2008). Perfluorocarbon emulsions improve cognitive recovery after lateral fluid percussion brain injury in rats. Neurosurgery 63, 799-806.
34. Schroeder, J.L., Highsmith, J.M., Young, H.F., and Mathern, B.E. (2008). Reduction of hypoxia by perfluorocarbon emulsion in a traumatic spinal cord injury model. J. Neurosurg. Spine 9, 213-220.
35. Basso, D.M., Beattie, M.S., and Bresnahan, J.C. (1996). Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244-256.
36. Gruner, J.A. (1992). A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma 9, 123-126.
37. Basso, D.M., Beattie, M.S., and Bresnahan, J.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21.
38. DeGirolami, U., and Zinvin, J.A. (1982). Neuropathology of experimental spinal cord ischemia in the rabbit. J. Neuropathol. Exp. Neurol. 41, 129-149.
39. Beattie, M.S., Farooqui, A.A., and Bresnahan, J.C. (2000). Review of current evidence for apoptosis after spinal cord injury. J. Neurotrauma 17, 915-925.
40. Casha, S., Yu, W.R., and Fehlings, M.G. (2001). Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103, 203-218.
41. Crowe, M.J., Bresnahan, J.C., Shuman, S.L., Masters, J.N., and Beattie, M.S. (1997). Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73-76.
42. Katoh, K., Ikata, T., Katoh, S., Hamada, Y., Nakauchi, K., Sano, T., and Niwa, M. (1996). Induction and its spread of apoptosis in rat spinal cord after mechanical trauma. Neurosci. Lett. 20, 9-12.
43. Raff, M.C., Barres, B.A., Burne, J.F., Coles, H.S., Ishizaki, Y., and Jacobson, M.D. (1993). Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262, 695-700.
44. Amar, A.P., and Levy, M.L. (1999). Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44, 1027-1039.
45. Faden, A.I., Demediuk, P., Panter, S.S., and Vink, R. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244, 798-800.
46. Vaccaro, A.R., Ahmad, S.S., Rauschning, W., and Garfin, S.R. (1998). Anatomy and pathophysiology of spinal cord injury, in: Spine Trauma. A.M. Levine, F.J. Eismont, S.R. Garfin, and J.E. Zigler (eds). WB Saunders: Philadelphia, PA, pps. 75-86.
47. Sandler, A.N., and Tator, C.H. (1976). Effect of acute spinal cord compression injury on regional spinal blood flow in primates. J. Neurosurg. 45, 660-676.
48. Senter, H.J., and Venes, J.L. (1978). Altered blood flow and secondary injury in experimental spinal cord trauma. J. Neurosurg. 49, 569-578.
49. Yanagawa, Y., Marcillo, A., Garcia-Rojas, R., Loor, K.E., and Dietrich, W.D. (2001). Influence of posttraumatic hypoxia on behavioral recovery and histopathological outcome following moderate spinal cord injury in rats. J. Neurotrauma 18, 635-644.
50. Moore, W.M., Jr., and Hollier, L.H. (1991). The influence of severity of spinal cord ischemia in the etiology of delayed-onset paraplegia. Ann. Surg. 213, 427-431; discussion, 431-432.
51. Fehlings, M.G., and Tator, C.H. (1995). The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. 132, 220-228.
52. Rosenberg, L.J., and Wrathall, J.R. (1997). Quantitative analysis of acute pathology in experimental spinal cord contusion. J. Neurotrauma 14, 823-838.
53. Basso, D.M. (2004). Behavioral testing after spinal cord injury: congruities, complexities, and controversies. J. Neurotrauma 21, 395-404.
54. McKenna, J.E., and Whishaw, I.Q. (1999). Complete compensation in skilled reaching success with associated impairments in limb synergies, after dorsal column lesion in the rat. J. Neurosci. 19, 1885-1894.
55. Lee, K.D., Chow, W.N., Sato-Bigbee, C., Graf, M.R., Graham, R.S., Colello, R.J., Young, H.F., and Mathern, B.E. (2009). FTY720 reduces inflammation and promotes functional recovery after spinal cord injury. J. Neurotrauma 12, 2335-2344.